References |
Top |
REF 1 |
Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem. 1997 Nov 28;272(48):30429-38.
|
REF 2 |
Ligand-independent activation of oestrogen receptor alpha by caveolin-1. Biochem J. 2001 Oct 1;359(Pt 1):203-10.
|
REF 3 |
The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor through spatial relocalization at helix 7 of its ligand-binding domain. Mol Cell Biol. 2011 Aug;31(16):3497-510.
|
REF 4 |
Tissue factor induction by protease-activated receptor 1 requires intact caveolin-enriched membrane microdomains in human endothelial cells. J Thromb Haemost. 2007 Dec;5(12):2437-44.
|
REF 5 |
Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J Biol Chem. 2001 Sep 14;276(37):34975-82.
|
REF 6 |
SHP-2 binds to caveolin-1 and regulates Src activity via competitive inhibition of CSK in response to H2O2 in astrocytes. PLoS One. 2014 Mar 14;9(3):e91582.
|
REF 7 |
Ubiquitination of the N-terminal region of caveolin-1 regulates endosomal sorting by the VCP/p97 AAA-ATPase. J Biol Chem. 2013 Mar 8;288(10):7363-72.
|
REF 8 |
Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells. J Biol Chem. 2007 Nov 16;282(46):33284-94.
|
REF 9 |
Kv1.5 association modifies Kv1.3 traffic and membrane localization. J Biol Chem. 2008 Mar 28;283(13):8756-64.
|
REF 10 |
Aquaporin 3 colocates with phospholipase d2 in caveolin-rich membrane microdomains and is downregulated upon keratinocyte differentiation. J Invest Dermatol. 2003 Dec;121(6):1487-95.
|